Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer’s disease

Fig. 4

Upregulated mRNA expression of CXCL16 in peripheral blood of patients with MCI and AD. Datasets of (A) GSE63060 (104 controls, 80 MCI, and 145 AD patients) and (B) GSE63061 (134 controls, 109 MCI, and 139 AD patients) [42] were used for determining CXCL16 mRNA expression levels. Data from min to max were presented by dots. *, P < 0.05; **, P < 0.01; two-tailed Student’s t-test

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193